Arcadia Biosciences
RKDA
12 hedge funds and large institutions have $1.35M invested in Arcadia Biosciences in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
51% more capital invested
Capital invested by funds: $894K → $1.35M (+$456K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
9% more funds holding
Funds holding: 11 → 12 (+1)
0.05% less ownership
Funds ownership: 0.15% → 0.1% (-0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$319K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$71.9K |
| 3 |
D.E. Shaw & Co
New York
|
+$55.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$48.9K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$5.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$303K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$175K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$71K |
| 4 |
VF
Virtu Financial
New York
|
-$62.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $558K | +$319K | +1,525 | +327% |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $280K | – | – | – |
|
3
Dimensional Fund Advisors
Austin,
Texas
| $161K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $96K | -$62.3K | -298 | -46% |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $96K | +$71.9K | +344 | New |
|
|
6
D.E. Shaw & Co
New York
| $74K | +$55.6K | +266 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $66K | +$48.9K | +234 | New |
|
|
AG
8
Advisor Group
Phoenix,
Arizona
| $14K | +$5.22K | +25 | +100% |
|
|
SWM
9
SeaCrest Wealth Management
Purchase,
New York
| $3K | – | – | – |
|
10
BlackRock
New York
| $2K | – | – | – |
|
|
SM
11
Sabby Management
Miami Beach,
Florida
| – | -$303K | -2,394 | Closed |
|
|
AFM
12
Anson Funds Management
Dallas,
Texas
| – | -$175K | -1,383 | Closed |
|
|
OAM
13
Oxford Asset Management
Oxford,
United Kingdom
| – | -$71K | -557 | Closed |
|
14
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$627 | +3 | New |
|
RKDA Hedge Fund Activity: Q1 2019 in Review
12 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2019, worth a combined $1.35M — up 51% from $894K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RKDA positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $319K. The largest seller was Sabby Management, exiting entirely with an estimated $303K sold.
- 12 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2019, up from 11 in Q4 2018.
- Funds reported $1.35M of Arcadia Biosciences stock for Q1 2019, up 51% quarter-over-quarter.
- 4 funds opened new Arcadia Biosciences positions in Q1 2019 and 3 closed out, a net change of +1 holder.
- The largest Arcadia Biosciences buyer in Q1 2019 was Vanguard Group, an estimated $319K added.
- The largest Arcadia Biosciences seller in Q1 2019 was Sabby Management, an estimated $303K sold.
Based on aggregated 13F filings for Q1 2019.